Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G. Cammarota is active.

Publication


Featured researches published by G. Cammarota.


Journal of General Virology | 1997

Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma

Fabrizio Maggi; Claudia Fornai; Maria Linda Vatteroni; Massimo Giorgi; Antonietta Morrica; Mauro Pistello; G. Cammarota; Santino Marchi; P. Ciccorossi; A. Bionda; Mauro Bendinelli

Hepatitis C virus (HCV) exists in vivo as a highly variable mixture of closely related genomes (quasispecies), but the pathogenetic significance of such heterogeneity is still largely unknown. To investigate this issue, we compared the composition of HCV quasispecies found in the liver, peripheral blood mononuclear cells (PBMC) and plasma of ten patients by single-strand conformation polymorphism analysis of the E2/NS1 region and sequencing of the variants detected. We found considerable quasispecies differences between the liver and PBMC in all the patients, involving variant numbers, relative quantities and relative electrophoretic mobilities, but no apparent tissue-specific trend. Genome variants present in the liver and/or PBMC were not detected in the corresponding plasma samples, while certain HCV variants were present only in plasma. No dominant amino acids or amino acid pattern characteristic of variants present solely in the PBMC were detected in the E2/NS1 region sequenced.


Journal of General Virology | 1997

Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B

Mauro Pistello; G. Cammarota; Elisa Nicoletti; Donatella Matteucci; M. Curcio; Daniela Del Mauro; Mauro Bendinelli

The genetic diversity of 32 Italian isolates of feline immunodeficiency virus (FIV) was studied. Isolates were obtained from domestic cats living in different areas. Sequence data were obtained from a 308 bp fragment of the p25 region of the gag gene. Phylogenetic relationships among these sequences and previously published sequences were determined. All the Italian isolates could be assigned to subtype B; however, four isolates formed two separate clusters and may represent genetic outliers. The reliability of classification results was confirmed by repeating the phylogenetic analysis with DNA sequences from the entire gag genes of two isolates and from the surface glycoprotein domain of the env gene of four isolates. It is concluded that the short segment of gag used permits reliable genotyping of FIV isolates. The study also shows that subtype B is largely prevalent in Italy.


Journal of Virology | 2001

During Readaptation In Vivo, a Tissue Culture-Adapted Strain of Feline Immunodeficiency Virus Reverts to Broad Neutralization Resistance at Different Times in Individual Hosts but through Changes at the Same Position of the Surface Glycoprotein

Mauro Bendinelli; Mauro Pistello; Daniela Del Mauro; G. Cammarota; Fabrizio Maggi; Alessandro Leonildi; Simone Giannecchini; Carlo Bergamini; Donatella Matteucci

ABSTRACT The broad resistance to antibody-mediated neutralization of lentiviruses recently isolated from infected hosts is a poorly understood feature which might contribute to the ability of these viruses to persist and to the failure of experimental vaccines to protect against virulent viruses. We studied the underlying molecular mechanisms by examining the evolution of a neutralization-sensitive, tissue culture-adapted strain of feline immunodeficiency virus upon reinoculation into specific-pathogen-free cats. Reversion to broad neutralization resistance was observed in seven of seven inoculated animals and, in individual hosts, started to develop between less than 4 and more than 15 months from infection. After comparison of the envelope sequences of the inoculum virus, of an additional 4 neutralization-sensitive in vitro variants, and of 14 ex vivo-derived variants (6 neutralization sensitive, 5 resistant, and 3 with intermediate phenotype), a Lys→Asn or →Glu change at position 481 in the V4 region of the surface glycoprotein appeared as a key player in the reversion. This conclusion was confirmed by mutagenesis of molecularly cloned virus. Analysis of viral quasispecies and biological clones showed that the intermediate phenotype was due to transient coexistence of neutralization-sensitive and -resistant variants. Since the amino acid position involved was the same in four of four recent revertants, it is suggested that the number of residues that control reversion to broad neutralization resistance in FIV might be very limited. Amino acid 481 was found to be changed only in one of three putative long-term revertants. These variants shared a Ser→Asn change at position 557 in region V5, which probably collaborated with other mutations in long-term maintenance of neutralization resistance, as suggested by the study of mutagenized virus.


Digestive and Liver Disease | 2000

Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against.

G. Cammarota; V. Pasceri; A. Gasbarrini; G. Gasbarrini

Helicobacter pylori is one of four organisms often investigated for ari association with ischaemic heart disease. The four, including Chlamydia pneumoniae, Cytomegalovirus and Herpes virus, cause low-grade, life-long infections that can produce a persistent inflammation, the kind that leads to heart disease. Several studies suggest an association, but others suggest none. Patients with poor access to medical care are more likely to become infected and also more likely to suffer from coronary artery disease. Although the literature data are provocative and interesting, the two things may not be related. Helicobacter pylori infection is quite prevalent among individuals without ischaemic heart disease and absent in many of those with ischaemic heart disease. Thus, more definite answers about whether there is any link between Helicobacter pylori and cardiovascular disease are needed. It would be essential to establish the specific mechanisms that possibly confer vulnerability or protection toward coronaropathy. But a definite answer could come from clinical trials designed to test whether antibiotics can prevent the disease. Until now, no randomised trial has suggested a positive effect of Helicobacter pylori eradication in reducing the incidence of cardiac events.


Journal of Virological Methods | 1996

Quantitation of feline immunodeficiency proviruses in doubly infected cats using competitive PCR and a fluorescence-based RFLP

G. Cammarota; Luigi Da Prato; Elisa Nicoletti; Donatella Matteucci; Mauro Bendinelli; Mauro Pistello

A nested polymerase chain reaction assay, which amplifies a region of the gag gene, was developed for the direct detection of feline immunodeficiency virus (FIV) DNA sequences in the blood of infected cats. This method detects as few as ten copies of a plasmid containing the whole genome of the FIV-Pet isolate on agarose gel. To distinguish two FIV isolates in double infected cats, we devised an RFLP analysis on PCR amplified products exploiting sequence differences in the gag gene of the two strains. To quantitate the two strains, a fluorescent inner-sense primer was used in the second amplification step. Amplicons were subsequently digested, heat-denatured and loaded on a polyacrylamide gel in an automated DNA sequencer. The proportion of the two isolates was determined using the laser-excited fluorescence of labelled strain specific fragments. These data were used to extrapolate the numbers of proviral genomes from the total viral load as estimated by using a competitive PCR assay. These sensitive and specific assays complement virological detection of FIV and enable superinfection studies to be evaluated; a prerequisite for the testing of live attenuated immunodeficiency virus vaccines.


Journal of Virology | 1994

A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.

S Lombardi; C Garzelli; Mauro Pistello; C Massi; Donatella Matteucci; Fulvia Baldinotti; G. Cammarota; L da Prato; P Bandecchi; Franco Tozzini


Molecular and Cellular Probes | 1994

COMPETITIVE POLYMERASE CHAIN REACTION FOR QUANTITATING FELINE IMMUNODEFICIENCY VIRUS LOAD IN INFECTED CAT TISSUES

Mauro Pistello; Stefano Menzo; Massimo Giorgi; Luigi Da Prato; G. Cammarota; Massimo Clementi; Mauro Bendinelli


Journal of Clinical Microbiology | 1995

Partial nucleotide sequencing of six subtype 2c hepatitis C viruses detected in Italy.

G. Cammarota; F Maggi; M L Vatteroni; L Da Prato; L Barsanti; Mauro Bendinelli; Mauro Pistello


Journal of Virology | 1999

Kinetics of Replication of a Partially Attenuated Virus and of the Challenge Virus during a Three-Year Intersubtype Feline Immunodeficiency Virus Superinfection Experiment in Cats

Mauro Pistello; Donatella Matteucci; G. Cammarota; Paola Mazzetti; Simone Giannecchini; Daniela Del Mauro; Sabina Macchi; Lucia Zaccaro; Mauro Bendinelli


Third international feline retrovirus research symposium | 1996

Pre-infection with a poorly pathogenic FIV does not prevent infection by a fully virulent heterologous strain

Mauro Pistello; Donatella Matteucci; G. Cammarota; Paola Mazzetti; Lucia Zaccaro; L Da Prato; Simone Giannecchini; Elisa Nicoletti; Solange Silva; Alessandro Poli; Franco Tozzini; Mauro Bendinelli

Collaboration


Dive into the G. Cammarota's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Riccardo Urgesi

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Rossella Cianci

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Vittoria Vero

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge